Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ASP Isotopes (ASPI) Operating Expenses (2022 - 2025)

ASP Isotopes has reported Operating Expenses over the past 4 years, most recently at $27.1 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 228.39% to $27.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $63.3 million, a 126.5% increase, with the full-year FY2025 number at $63.3 million, up 126.5% from a year prior.
  • Operating Expenses reached $27.1 million in Q4 2025 per ASPI's latest filing, up from $15.4 million in the prior quarter.
  • The five-year high for Operating Expenses was $27.1 million in Q4 2025, with the low at $827959.0 in Q2 2022.
  • The 4-year median for Operating Expenses is $5.0 million (2023), against an average of $7.0 million.
  • Peak YoY movement for Operating Expenses: soared 425.09% in 2023, then surged 35.86% in 2025.
  • Tracing ASPI's Operating Expenses over 4 years: stood at $1.5 million in 2022, then soared by 185.26% to $4.2 million in 2023, then skyrocketed by 98.3% to $8.3 million in 2024, then soared by 228.39% to $27.1 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $27.1 million, $15.4 million, and $12.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.